In June 2018, the FDA approved GW Pharmaceutical's Epidiolex, a CBD-based drug for treating epileptic seizures - marking the first time the agency has ever approved a drug derived from marijuana.
IDVV
(0)
(0)
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch
benzingaheadline@gmail.com.
Target readers who trust our platform to stay ahead of the curve.
